Skip to main content
Have a personal or library account? Click to login
Prediction of Ki-67 expression in hepatocellular carcinoma: a dual-center study based on T2-weighted imaging habitat analysis Cover

Prediction of Ki-67 expression in hepatocellular carcinoma: a dual-center study based on T2-weighted imaging habitat analysis

Open Access
|Jun 2026

References

  1. Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2024; 74: 229-63. doi: 10.3322/caac.21834
  2. Yang M, Song X, Zhang F, Li M, Chang W, Wang Z, et al. Spatial proteomic landscape of primary and relapsed hepatocellular carcinoma reveals immune escape characteristics in early relapse. Hepatology 2025; 81: 1452-67. doi: 10.1097/HEP.0000000000000979
  3. Jones A, Kroneman TN, Blahnik AJ, Graham RP, Mounajjed T, Torbenson MS, et al. Ki-67 “hot spot” digital analysis is useful in the distinction of hepatic adenomas and well-differentiated hepatocellular carcinomas. Virchows Arch 2021; 478: 201-7. doi: 10.1007/s00428-020-02868-8
  4. Sun H, Wang H, Wang Y, Zhong W, Meng Y, Lv Z, et al. Adjuvant transarterial chemoembolization timing after radical resection is an independent prognostic factor for patients with hepatocellular carcinoma. Front Oncol 2023; 13: 1129065. doi: 10.3389/fonc.2023.1129065
  5. Meng L, Jiang Z, Shen G, Lin S, Gao F, Guo X, et al. Genetic alterations are related to clinicopathological features and risk of recurrence/metastasis of hepatocellular carcinoma. Eur J Cancer Prev 2025; 34: 456-66. doi: 10.1097/CEJ.0000000000000939
  6. Boukhar SA, Gosse MD, Bellizzi AM, Rajan KDA. Ki-67 proliferation index assessment in gastroenteropancreatic neuroendocrine tumors by digital image analysis with stringent case and hotspot level concordance requirements. Am J Clin Pathol 2021; 156: 607-19. doi: 10.1093/ajcp/aqaa275
  7. Lucas O, Ward S, Zaidi R, Bunkum A, Frankell AM, Moore DA, et al. Characterizing the evolutionary dynamics of cancer proliferation in singlecell clones with SPRINTER. Nat Genet 2025; 57: 103-14. doi: 10.1038/s41588-024-01989-z
  8. Jagtap SV. Evaluation and prediction of Ki-67 expression in hepatocellular carcinoma. World J Gastrointest Oncol 2025; 17: 106529. doi: 10.4251/wjgo.v17.i10.106529
  9. Xia TY, Zhou ZH, Meng XP, Zha JH, Yu Q, Wang WL, et al. Predicting microvascular invasion in hepatocellular carcinoma using CT-based radiomics model. Radiology 2023; 307: e222729. doi: 10.1148/radiol.222729
  10. Liu HF, Wang M, Wang Q, Lu Y, Lu YJ, Sheng Y, et al. Multiparametric MRIbased intratumoral and peritumoral radiomics for predicting pathological differentiation of hepatocellular carcinoma. Insights Imaging 2024; 15: 97. doi: 10.1186/s13244-024-01623-w
  11. Huang Y, Chen L, Ding Q, Zhang H, Zhong Y, Zhang X, et al. CT-based radiomics for predicting pathological grade in hepatocellular carcinoma. Front Oncol 2024; 14: 1295575. doi: 10.3389/fonc.2024.1295575
  12. Romeo D, Richter T, Höhn AK, Tautenhahn HM, Seehofer D, Scheuermann U, et al. Associations between the SMARS score derived from CT and MRI with histopathological features in HCC. Sci Rep 2025; 15: 24862. doi: 10.1038/s41598-025-09918-8
  13. Zhang Q, Lou Y, Bai XL, Liang TB. Intratumoral heterogeneity of hepatocellular carcinoma: from single-cell to population-based studies. World J Gastroenterol 2020; 26: 3720-36. doi: 10.3748/wjg.v26.i26.3720
  14. Yang C, Zhang S, Cheng Z, Liu Z, Zhang L, Jiang K, et al. Multi-region sequencing with spatial information enables accurate heterogeneity estimation and risk stratification in liver cancer. Genome Med 2022; 14: 142. doi: 10.1186/s13073-022-01143-6
  15. Li H, Zhang J, Liu B, Zheng Z, Xu Y. Histogram analysis of multiple mathematical diffusion-weighted imaging models for preoperative prediction of Ki-67 expression in hepatocellular carcinoma. Front Oncol 2025; 15: 1531236. doi: 10.3389/fonc.2025.1531236
  16. Zhu Y, Wang J, Xue C, Zhai X, Xiao C, Lu T. Deep learning and habitat radiomics for the prediction of glioma pathology using multiparametric MRI: a multicenter study. Acad Radiol 2025; 32: 963-75. doi: 10.1016/j.acra.2024.09.021
  17. Jhan SR, Wu YY, Chang PY, Chai JW, Su TC. Comparison of lesion detection ability of two MRI sequences of T2WI HASTE and T2WI BLADE for hepatocellular carcinoma. Medicine (Baltimore) 2023; 102: e32890. doi: 10.1097/MD.0000000000032890
  18. Murakami K, Kasajima A, Kawagishi N, Ohuchi N, Sasano H. Microvessel density in hepatocellular carcinoma: prognostic significance and review of previous published work. Hepatol Res 2015; 45: 1185-94. doi: 10.1111/hepr.12487
  19. Jones A, Kroneman TN, Blahnik AJ, Graham RP, Mounajjed T, Torbenson MS, et al. Ki-67 “hot spot” digital analysis is useful in the distinction of hepatic adenomas and well-differentiated hepatocellular carcinomas. Virchows Arch 2021; 478: 201-7. doi: 10.1007/s00428-020-02868-8
  20. Boukhar SA, Gosse MD, Bellizzi AM, Rajan KDA. Ki-67 proliferation index assessment in gastroenteropancreatic neuroendocrine tumors by digital image analysis with stringent case and hotspot level concordance requirements. Am J Clin Pathol 2021; 156: 607-19. doi: 10.1093/ajcp/aqaa275
  21. Nielsen TO, Leung SCY, Rimm DL, Dodson A, Acs B, Badve S, et al. Assessment of Ki67 in breast cancer: updated recommendations from the International Ki67 in Breast Cancer Working Group. J Natl Cancer Inst 2021; 113: 808-19. doi: 10.1093/jnci/djaa201
  22. Zhang W, Yue Z, Ye J, Xu H, Wang Y, Zhang X, et al. Modulation format identification using the Calinski-Harabasz index. Appl Opt 2022; 61: 851-7. doi: 10.1364/AO.448043
  23. Wang A, He M, Zhang C, Zheng Y, Song Y, Wang C, et al. Intravoxel incoherent motion-based habitat imaging for predicting immunohistochemistry in patients with breast cancer. Front Oncol 2025; 15: 1595157. doi: 10.3389/fonc.2025.1595157
  24. Yang X, Niu W, Wu K, Li X, Hou H, Tan Y, et al. Diffusion kurtosis imagingbased habitat analysis identifies high-risk molecular subtypes and heterogeneity matching in diffuse gliomas. Ann Clin Transl Neurol 2024; 11: 2073-87. doi: 10.1002/acn3.52128
  25. Ding Z, Zhang C, Xia C, Yao Q, Wei Y, Zhang X, et al. DCE-MRI-based deep learning analysis of intratumoral subregions for predicting Ki-67 expression level in breast cancer. Magn Reson Imaging 2025; 119: 110370. doi: 10.1016/j.mri.2025.110370
  26. Maestri E, Kedei N, Khatib S, Forgues M, Ylaya K, Hewitt SM, et al. Spatial proximity of tumor-immune interactions predicts patient outcome in hepatocellular carcinoma. Hepatology 2024; 79: 768-79. doi: 10.1097/HEP.0000000000000600
  27. Lei HJ, Wang SY, Chau IY, Li AF, Chau YP, Hsia CY, et al. Hepatoma upregulated protein and Ki-67 expression in resectable hepatocellular carcinoma. J Chin Med Assoc 2021; 84: 623-32. doi: 10.1097/JCMA.0000000000000540
  28. Li HH, Qi LN, Ma L, Chen ZS, Xiang BD, Li LQ. Effect of Ki-67 positive cellular index on prognosis after hepatectomy in BCLC stage A and B hepatocellular carcinoma with microvascular invasion. Onco Targets Ther 2018; 11: 4747-54. doi: 10.2147/OTT.S165244
  29. Ma J, Li D, Zhu X. Influencing factors for tumor thrombus in patients with hepatocellular carcinoma. Gastrointest Oncol 2024; 15: 415-24. doi: 10.21037/jgo-23-983
  30. Liu Z, Yang S, Chen X, Luo C, Feng J, Chen H, et al. Nomogram development and validation to predict Ki-67 expression of hepatocellular carcinoma derived from Gd-EOB-DTPA-enhanced MRI combined with T1 mapping. Front Oncol 2022; 12: 954445. doi: 10.3389/fonc.2022.954445
  31. Ghamry HI. Impending chemotherapeutic impact of Arthrospira platensis nanoparticles and/or sorafenib against hepatocellular carcinoma through modulation of antioxidant status, tumor marker genes, and anti-inflammatory signaling pathways. Toxics 2023; 11: 107. doi: 10.3390/toxics11020107
  32. Yanai M, Kurata M, Muto Y, Iha H, Kanao T, Tatsuzawa A, et al. Clinicopathological and molecular analysis of SIRT7 in hepatocellular carcinoma. Pathology 2020; 52: 529-37. doi: 10.1016/j.pathol.2020.03.011
  33. Zhang X, Su GH, Chen Y, Gu YJ, You C. Decoding intratumoral heterogeneity: clinical potential of habitat imaging based on radiomics. Radiology 2023; 309: e232047. doi: 10.1148/radiol.232047
  34. Tomaszewski MR, Gillies RJ. The biological meaning of radiomic features. Radiology 2021; 298: 505-16. doi: 10.1148/radiol.2021202553
  35. Cai C, Wang L, Tao L, Zhu H, Ren Y, Li D, et al. Imaging-based prediction of Ki-67 expression in hepatocellular carcinoma: a retrospective study. Cancer Med 2025; 14: e70562. doi: 10.1002/cam4.70562
  36. Ye J, Lin Y, Liao Z, Gao X, Lu C, Lu L, et al. Single-cell spatial transcriptomics and bulk multi-omics analysis of heterogeneity and ecosystems in hepatocellular carcinoma. NPJ Precis Oncol 2024; 8: 262. doi: 10.1038/s41698-024-00752-1
DOI: https://doi.org/10.2478/raon-2026-0032 | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099
Language: English
Page range: 217 - 226
Submitted on: Nov 15, 2025
Accepted on: Apr 11, 2026
Published on: Jun 26, 2026
In partnership with: Paradigm Publishing Services

© 2026 Xiaojun Zheng, Lihong Huang, Mengjie Huang, Bin Yu, Shiji Qin, Deyou Huang, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons Attribution 4.0 License.